1. ALLA AKTIER
  2. NYHETER
  3. NEOLA MEDICAL

Neola Medical

Nyheter Neola Medical Nyheter alla bolag

Neola Medical Granted Patent in Europe, Expands Protection for Medical Device Neola®

Neola Medical AB has been granted a patent in Europe for a technical method and equipment that enhance the accuracy of continuous measurements performed by the company’s medical device for lung monitoring, Neola®. This patent extends the protection for Neola® and strengthens the product’s competitiveness.

"The granting of this patent is a milestone in our intellectual property strategy, reinforcing our competitive edge in the market. By continuously expanding the protection of our product, we ensure that Neola® remains at the forefront of medical technology for neonatal care.", says CEO Hanna Sjöström.

The patent, now granted in Europe and previously granted in Sweden by the Swedish Patent and Registration Office, protects the company’s invention for compensating background signals, thereby improving the accuracy of measurements in the company’s product for continuous lung monitoring of preterm born infants.
The patent application is pending in the USA and China.

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical Granted Patent in Europe, Expands Protection for Medical Device Neola®

Datum 2024-08-07, kl 07:00
Källa MFN
Bifogade filer
Neola Medical Granted Patent in Europe, Expands Protection for Medical Device Neola®
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!